Dashenlin Pharm Grp Co Ltd (603233) — Cash Flow-to-Debt Ratio
Dashenlin Pharm Grp Co Ltd (603233) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥818.72 Million could theoretically repay 0% of its total liabilities (CN¥17.59 Billion) in one year. See Dashenlin Pharm Grp Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dashenlin Pharm Grp Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Dashenlin Pharm Grp Co Ltd across 14 annual periods. Also explore 603233 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dashenlin Pharm Grp Co Ltd (2012–2025)
Year-by-year debt coverage analysis for Dashenlin Pharm Grp Co Ltd. For market capitalisation and broader financial context, see 603233 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥5.35 Billion | CN¥17.83 Billion | ▲ +76.8% |
| 2024 | 0.17x | CN¥3.11 Billion | CN¥18.30 Billion | ▼ -13.4% |
| 2023 | 0.20x | CN¥3.17 Billion | CN¥16.19 Billion | ▼ -27.1% |
| 2022 | 0.27x | CN¥3.76 Billion | CN¥13.98 Billion | ▲ +97.0% |
| 2021 | 0.14x | CN¥1.55 Billion | CN¥11.40 Billion | ▼ -52.8% |
| 2020 | 0.29x | CN¥1.95 Billion | CN¥6.76 Billion | ▼ -26.5% |
| 2019 | 0.39x | CN¥1.71 Billion | CN¥4.34 Billion | ▲ +55.4% |
| 2018 | 0.25x | CN¥873.64 Million | CN¥3.45 Billion | ▲ +19.4% |
| 2017 | 0.21x | CN¥640.39 Million | CN¥3.02 Billion | ▼ -4.2% |
| 2016 | 0.22x | CN¥495.60 Million | CN¥2.24 Billion | ▼ -22.6% |
| 2015 | 0.29x | CN¥468.59 Million | CN¥1.64 Billion | ▲ +14.2% |
| 2014 | 0.25x | CN¥448.58 Million | CN¥1.79 Billion | ▼ -5.2% |
| 2013 | 0.26x | CN¥288.22 Million | CN¥1.09 Billion | ▼ -43.8% |
| 2012 | 0.47x | CN¥289.31 Million | CN¥615.39 Million | — |